Lexicon Pharmaceuticals's total assets for Q2 2025 were $225.58M, a decrease of -24.22% from the previous quarter. LXRX total liabilities were $96.14M for the fiscal quarter, a -44.95% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.